These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 19015446)
1. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. Ngan BY; Forte V; Campisi P Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446 [TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Forooghian F; Das B Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF. Knowles HJ; Athanasou NA J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716 [TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties. Ben-Shoshan J; Schwartz S; Luboshits G; Maysel-Auslender S; Barzelay A; Polak-Charcon S; Tzahor E; Barshack I; Barak A; Levkovitch-Verbin H; Keren G; George J Stem Cells; 2008 Oct; 26(10):2634-43. PubMed ID: 18687993 [TBL] [Abstract][Full Text] [Related]
6. Expression of angiogenic and vasculogenic factors in human lymphedematous tissue. Couto RA; Kulungowski AM; Chawla AS; Fishman SJ; Greene AK Lymphat Res Biol; 2011; 9(3):143-9. PubMed ID: 22066744 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinomas of the head and neck. Neuchrist C; Erovic BM; Handisurya A; Steiner GE; Rockwell P; Gedlicka C; Burian M Laryngoscope; 2001 Oct; 111(10):1834-41. PubMed ID: 11801954 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. Jiang M; Wang B; Wang C; He B; Fan H; Guo TB; Shao Q; Gao L; Liu Y J Cell Biochem; 2008 Jan; 103(1):321-34. PubMed ID: 17541946 [TBL] [Abstract][Full Text] [Related]
9. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Brieger J; Wierzbicka M; Sokolov M; Roth Y; Szyfter W; Mann WJ Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):727-31. PubMed ID: 15210553 [TBL] [Abstract][Full Text] [Related]
10. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma. Zhu DM; Li DC; Zhang ZX; Zhang XY Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330 [TBL] [Abstract][Full Text] [Related]
11. Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. Sauer H; Bekhite MM; Hescheler J; Wartenberg M Exp Cell Res; 2005 Apr; 304(2):380-90. PubMed ID: 15748885 [TBL] [Abstract][Full Text] [Related]
12. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome. Comati A; Beck H; Halliday W; Snipes GJ; Plate KH; Acker T J Neuropathol Exp Neurol; 2007 Jan; 66(1):86-97. PubMed ID: 17204940 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells. Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348 [TBL] [Abstract][Full Text] [Related]
19. Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Passam FH; Alexandrakis MG; Kafousi M; Fotinou M; Darivianaki K; Tsirakis G; Roussou PA; Stathopoulos EN; Siafakas NM Pathol Res Pract; 2009; 205(1):11-20. PubMed ID: 18950958 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells. Nishimoto-Hazuku A; Hirase T; Ide N; Ikeda Y; Node K J Cardiovasc Pharmacol; 2008 Mar; 51(3):267-73. PubMed ID: 18356691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]